Diagnos Inc.

Diagnos Inc.

July 02, 2009 10:25 ET

DIAGNOS Announces Grant of Options

BROSSARD, QUEBEC, CANADA--(Marketwire - July 2, 2009) - DIAGNOS inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE:ADK), a leader in the use of artificial intelligence and advanced knowledge extraction techniques, announces that, on June 23, 2009, the Board of Directors has approved a grant of 287,684 stock options, to Mr Andre Larente, Chairman and CEO, under the terms of the share stock option plan of the Corporation approved by the Shareholders in September 2008.

The exercise price has been established at $0.14 per share. The expiry date where these options can be exercised has been fixed to June 22nd, 2014.


DIAGNOS can count on a multidisciplinary team that includes professionals in geophysics, geology, artificial intelligence, mathematics, information technology, as well as remote sensing and image interpretation.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com. You may also contact our investor relations representative.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information